Skip to main content
. 2017 Mar 13;13(5):2957–2964. doi: 10.3892/ol.2017.5847

Figure 4.

Figure 4.

Radiological tumor evaluation of a patient with intrahepatic cholangiocarcinoma during sorafenib treatment. (A) Baseline tumor evaluation showing a tumor of 7×6 cm in size. (B) Local tumor necrosis following 6 weeks of sorafenib treatment. (C) Local tumor necrosis with a decreased tumor size (5×4 cm) following sorafenib treatment for 12 weeks. CT evaluation following sorafenib treatment for (D) 25 weeks (tumor size, 5×4 cm), (E) 36 weeks, (F) 44 weeks and (G) 52 weeks.